ImportantCommencement of commercial production/operations

Aarti Drugs' new manufacturing plant in Sayakha, Gujarat, began commercial production with 60 MTPd capacity for specialty chemicals.

Aarti Drugs Limited logo
Aarti Drugs LimitedAARTIDRUGS · Filed with the exchange

The Rs 220 Cr investment aims for backward integration, enhancing supply chain reliability, and driving margin expansion.

Read the original filing(PDF)

No comments yet. Be the first.

More from Aarti Drugs Limited

All announcements